You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Abacavir (ABC)/Lamivudine (3TC)

Showing 1 - 25 of 1,009
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aicardi-Goutières Syndrome Trial in Edinburgh (Abacavir (ABC), Lamivudine (3TC), Abacavir (ABC)+Lamivudine (3TC)+Zidovudine

Recruiting
  • Aicardi-Goutières Syndrome
  • Abacavir (ABC)
  • +2 more
  • Edinburgh, United Kingdom
    Yanick Crow
Aug 26, 2022

HIV, Acute HIV Infection Trial in Chapel Hill, Durham (Dolutegravir 50 mg, Lamivudine 300 mg, Abacavir 600 mg)

Completed
Has Results
  • HIV
  • Acute HIV Infection
  • Dolutegravir 50 mg
  • +2 more
  • Chapel Hill, North Carolina
  • +1 more
Oct 22, 2021

HIV-1 Infection Trial in Worldwide (Lopinavir/ritonavir, Raltegravir, Emtricitabine/tenofovir disoproxil fumarate)

Completed
Has Results
  • HIV-1 Infection
  • Rio de Janeiro, Brazil
  • +15 more
Aug 3, 2021

HIV Trial (Abacavir sulfate, Didanosine, Efavirenz)

Completed
Has Results
  • HIV Infections
  • Abacavir sulfate
  • +6 more
  • (no location specified)
Oct 29, 2021

Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK744, GSK744 LA, TMC278 LA)

Active, not recruiting
Has Results
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Birmingham, Alabama
  • +49 more
Dec 26, 2022

Infection, Human Immunodeficiency Virus, HIV, Arthralgia Trial in Orel, St. Petersburg, Madrid (DTG 50 mg /ABC 600 mg /3TC 300

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • +2 more
  • DTG 50 mg /ABC 600 mg /3TC 300 mg FDC tablets
  • Orel, Russian Federation
  • +2 more
Sep 9, 2022

Abacavir and Lamivudine Anabolites

Completed
  • HIV-1-infection
  • Blood collection
  • +3 more
  • Aurora, Colorado
    University of Colorado Hospital
Jan 5, 2023

Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir/abacavir/lamivudine FDC, Atazanavir, Ritonavir)

Active, not recruiting
Has Results
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Dolutegravir/abacavir/lamivudine FDC
  • +3 more
  • Phoenix, Arizona
  • +88 more
Feb 8, 2022

HIV-1 Infection Trial in Worldwide (ABC/DTG/3TC, B/F/TAF, ABC/DTG/3TC Placebo)

Completed
Has Results
  • HIV-1 Infection
  • Birmingham, Alabama
  • +120 more
Feb 7, 2022

Hiv Trial in France (Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO])

Not yet recruiting
  • Hiv
  • Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]
  • Caen, France
  • +3 more
Sep 6, 2023

Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child

Completed
  • Human Immunodeficiency Virus Infection
  • Tenofovir Disoproxil Fumarate (TDF) 300 mg + Lamivudine (3TC) 300 mg + Efavirenz (EFV) 600 mg
  • +2 more
  • Adikpo, Benue State, Nigeria
  • +3 more
Oct 12, 2020

HIV-1-infection Trial in Montréal (abacavir, dolutegravir and lamivudine dispersible tablets, Triumeq Dispersible Tablets 5 mg

Completed
  • HIV-1-infection
  • abacavir, dolutegravir and lamivudine dispersible tablets
  • Triumeq Dispersible Tablets 5 mg GSK1349572 [Dolutegravir]/ 60 mg Abacavir/ 30 mg Lamivudine
  • Montréal, Quebec, Canada
    Altasciences
Mar 10, 2022

HIV Trial in Worldwide (GSK3640254, ABC/3TC, FTC/TAF)

Active, not recruiting
  • HIV Infections
  • Los Angeles, California
  • +65 more
Jul 18, 2022

Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)

Active, not recruiting
  • Hiv
  • HIV-1-infection
  • Lamivudine 300 MG
  • Emtricitabine / Tenofovir Disoproxil Pill
  • Buenos Aires, Argentina
    Fundacion IDEAA
Jan 2, 2023

HIV Trial in Worldwide (Dolutegravir film-coated tablets, Dolutegravir film-coated dispersible tablets, ABC/DTG/3TC immediate

Recruiting
  • HIV Infections
  • Dolutegravir film-coated tablets
  • +3 more
  • Los Angeles, California
  • +16 more
Sep 29, 2022

AIDS Trial (Dolutegravir 50 MG plus lamivudine 300 MG; Dolutegravir/lamivudine (50 MG/300 MG))

Not yet recruiting
  • Acquired Immunodeficiency Syndrome
  • Dolutegravir 50 MG plus lamivudine 300 MG； Dolutegravir/lamivudine (50 MG/300 MG)
  • (no location specified)
Aug 6, 2022

HIV I Infection Trial in Orlando (Dolutegravir / Lamivudine Pill, Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill)

Active, not recruiting
  • HIV I Infection
  • Dolutegravir / Lamivudine Pill
  • Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill
  • Orlando, Florida
    Orlando Immunology Center
Sep 20, 2022

Tuberculosis, HIV Trial (Dolutegravir, 3HP)

Not yet recruiting
  • Tuberculosis
  • HIV
  • (no location specified)
Dec 9, 2022

Patients' Experiences and Perceptions of 3TC/DTG Dual Therapy

Active, not recruiting
  • HIV Infections
  • Cultural Domain Analysis
  • +2 more
  • Brighton, United Kingdom
    Royal Sussex County Hospital, Brighton, UK
May 18, 2022

HIV Trial (DTG/3TC, Cabotegravir (CAB) LA, Rilpivirine (RPV) LA)

Not yet recruiting
  • HIV Infections
  • (no location specified)
Jun 13, 2023

HIV Trial (Influenza Virus Vaccine, Pneumococcal Vaccine, Polyvalent (23-valent), Lamivudine)

Withdrawn
  • HIV Infections
  • Influenza Virus Vaccine
  • +2 more
  • (no location specified)
Oct 28, 2021

HIV Trial in South Africa, Thailand, United States (Doravirine (DOR), Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate

Completed
Has Results
  • HIV Infections
  • Doravirine (DOR)
  • +2 more
  • Aurora, Colorado
  • +7 more
Sep 30, 2022

HIV Trial in Majadahonda, Madrid (ELV/COBI/FTC/TAF, DTG/3TC/ABC + ELV/COBI/FTC/TAF)

Completed
  • HIV Infections
  • Majadahonda, Madrid, Spain
  • +5 more
Feb 3, 2020

HIV Trial in Puerto Rico, United States (Abacavir sulfate, lamivudine, and zidovudine, Lamivudine/zidovudine,

Completed
  • HIV Infections
  • Abacavir sulfate, lamivudine, and zidovudine
  • +2 more
  • Los Angeles, California
  • +7 more
Oct 28, 2021

HIV, Drug Resistance, Drug Drug Interaction Trial in Switzerland (DOR/DTG/3TC)

Not yet recruiting
  • HIV
  • +2 more
  • Basel, Switzerland
  • +6 more
Sep 7, 2023